The specificity was verified by evaluating the cytotoxic efficacy of ETAST isolated from the blood of patients with cancer against autologous cancer cells from tumor tissues; CD3+CD137+ ETASTs were isolated from the peripheral blood of two lungs of patients with cancer mTC NPs loaded with mixed lysates of seven lung cancer cell lines. This evidence concerns the gene TNFRSF9 and neoplasm.